Vitamin D and Calcium Supplement Attenuate Bone Loss among HIV-infected Patients Receiving Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz: An Open-label, randomized Controlled Trial.

CONCLUSION: Vitamin D2 and calcium supplements should be considered for HIV-infected patients receiving TDF/FTC/EFV in a resource-limited setting where there are limited ART options (Clinicaltrials.gov NCT0287643). PMID: 31906840 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31906840?dopt=Abstract

Source: Current HIV Research - January 5, 2020 Category: Infectious Diseases Authors: Boontanondha P, Nimitphong H, Musikarat S, Ragkho A, Kiertiburanakul S Tags: Curr HIV Res Source Type: research